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ABSTRACT
Photocaged adenosine triphosphate (ATP) is one of the earliest examples of exerting spatialtemporal control over the activity of a substrate. The activity of ATP is blocked until nearultraviolet light exposure photocleaves the cage moiety. Caged ATP has been used for a myriad
of applications including kinetic studies of ATP-dependent enzymes. Traditional caging of ATP
occurs at the γ-phosphate, which has been found to competitively inhibit several enzymatic
systems. It was hypothesized that blocking access to the adenosine N6 position via cage
molecule would prevent the initial enzyme-substrate binding event from occurring prior to
photolysis, effectively minimizing competitive inhibition. Utilizing a convertible nucleoside
analog of ATP, this work synthesized, purified, and characterized a form of caged ATP which,
by attaching the cage molecule to the nucleobase, did not inhibit the enzymatic activity of
luciferase in vitro. Characterization was accomplished via UV/Vis spectroscopy, high
performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR), and mass
spectrometry (MS). Base-caged ATP was evaluated in a firefly luciferase enzymatic assay to
determine the degree of bioactivity in the caged and photoactivated states and compared to the
results of native (uncaged) ATP and γ-NPE-caged ATP. Photolysis was conducted via 308 nm
light from a transilluminator. Base-caged ATP did not inhibit the enzymatic system and the
convertible nucleoside synthesis approach offers significant advantages over other caging
techniques.

viii

CHAPTER 1 – BACKGROUND AND SIGNIFICANCE
1.1

Objectives

Base-caged adenosine triphosphate as a model system for photoactivatable siRNA.
1. Synthesize base-caged ATP.
2. Purify base-caged ATP through separation techniques.
3. Characterize results through analytical chemistry.
4. Demonstrate:
A. Bio-inactive in base-caged form;
B. Photolysis restores bioactivity;
C. Confirm that base-caged form does not inhibit enzymatic systems.

1.2

Introduction
Developments in the field of tissue regeneration and engineering include advances in the

use of biomaterials and stem cells, scaffolds, growth and differentiation factors, and biomimetic
environments to achieve three-dimensional cell cultures (Takahashi, Ogasawara et al. 2007).
Despite numerous improvements, much work remains to perfect clinically applicable growth of
complex tissues. One of the primary challenges in tissue growth arises from the lack of complex
control techniques to direct pluripotent cell differentiation.
A plausible method to enhance tissue repair and regeneration is by the modification and
exploitation of the RNA interference (RNAi) mechanism to silence gene expression (Mack 2007;
Casey, Blidner et al. 2009). Spatial-temporal control is introduced when RNAi techniques are
coupled with an external trigger through the utilization of photocaging. Photocaging involves
chemically modifying the molecule of interest with a photolabile compound that inhibits

bioactivity until released with a specific wavelength of light (Casey, Blidner et al. 2009). As
such, caged RNA oligonucleotides are inactive and do not participate in RNAi until exposed to
light, which can be readily pinpointed with temporal and spatial precision.
The primary aim of this work was to develop a precise photocaging process utilizing
base-caged adenosine triphosphate (ATP) as a model system for the RNA nucleoside adenosine.

1.3

RNA Interference
The first element of directed tissue growth and regeneration stems from the discovery of

RNA interference (RNAi). RNAi plays a large role in determining the activity of genes by
turning them on, off, up regulating, or down regulating their expression. The manipulation of
gene expression with RNA was revolutionized by the findings of Nobel laureates Fire and Mello,
who were among the first to characterize and exploit RNAi through the use of small doublestranded RNA molecules known as small interfering RNAs (siRNAs) (Fire, Xu et al. 1998).
Subsequent studies have shown that cell differentiation and proliferation can be regulated via
RNAi gene silencing (Chen, Mandel et al. 2006). Transient inhibition with siRNAs would
enable the finely tuned regulation of cell differentiation that is needed for the successful growth
of musculoskeletal tissue in vitro (Rhim, Lowell et al. 2007).

1.3.1 RNA Interference Mechanism
RNA interference is a post-transcriptional gene regulation mechanism in eukaryotic
organisms. The aforementioned small interfering RNAs (siRNAs) comprise a class of dsRNA of
20-25 nucleotides in length. Native RNAs which participate in this pathway are single-stranded
2

RNA called microRNAs (miRNAs) of 21-25 nucleotides in length (He and Hannon 2004). The
expression of a specific gene is moderated by miRNAs or siRNAs which hybridize with a
complementary strand of mRNA. This hybridization silences the mRNA’s activity by repressing
translation or cleaving the mRNA (He and Hannon 2004; Gregory, Chendrimada et al. 2005;
Rhim, Lowell et al. 2007).
Native miRNA genes contain one or more 60-120 nucleotide-long segments exhibiting
sufficient reverse sequence complementarity to spontaneously form hairpin-loop structures
(Hartwell, Hood et al. 2008). The initial transcription product is known as primary miRNA (primiRNA). After transcription, the pri-miRNA is recognized by the nuclear enzyme Drosha,
which crops the RNA at the base of the structure to remove the 5’ mG cap and the 3’ poly-A tail
(Hartwell, Hood et al. 2008). Drosha releases a 65-75-nt form called pre-miRNA which is
transported to the cytoplasm by Exportin-5-mediated nuclear transport (Yi, Qin et al. 2003).
Once in the cytoplasm of the cell, a ribonuclease (RNase-III) called Dicer recognizes the premiRNA. Dicer cuts the loop off the pre-miRNA to produce the mature 21-24 ribonucleotide
miRNA and its complement miRNA* (He and Hannon 2004; Hartwell, Hood et al. 2008). When
long dsRNA molecules are found in the cytoplasm, Dicer also processes these into siRNA
duplexes (He and Hannon 2004). These duplexes are further processed by a ribonucleoprotein
effector complex called the RNA-induced silencing complex (RISC) (Gregory, Chendrimada et
al. 2005). The RNase component of the RISC degrades the miRNA* and complementary siRNA
strands (He and Hannon 2004; Winter, Jung et al. 2009), and the miRNA/siRNA-loaded RISC
complex (miRISC/siRISC) becomes an active agent of RNA interference. The formation of
miRNA and siRNA silencing complexes are graphically shown in Figure 1.
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Figure 1 – Model for the biogenesis and post
post-transcriptional
transcriptional suppression by miRNAs and
siRNAs.
Initial primary microRNA (pri-miRNA)
miRNA) transcripts are cleaved inside the nucleus into 65-75-nt
pre-miRNAs by Drosha. Pre-miRNAs
miRNAs are transported to the cytoplasm by Exportin 5 and are
processed into miRNA:miRNA* duplexes by Dicer. Dicer also cleaves long dsRNA molecules
mole
into siRNA duplexes. Only one strand of the miRNA:miRNA* duplex or th
thee siRNA duplex is
assembled into the RNA-induced
nduced silencing complex (RISC). The assembled RISC
translationally represses or cleaves mRNAs depending on the degree of complementarity
complementari
between the miRNA or siRNA and the target mRNA. Reprinted by permission from Macmillan
Publishers Ltd: Nature Reviews Genetics 5, 522-531 (July 2004), copyright
pyright 2004.
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RNA interference exhibits two forms of post-transcriptional control of gene expression,
as seen in Figure 1. The precise mode of RNAi depends on the degree of complementarity
between the miRNA or siRNA and the target mRNA (He and Hannon 2004; Hartwell, Hood et
al. 2008). The first mode occurs when the miRISC/siRISC sequence hybridizes in a perfectly
base-paired complex with the mRNA; the miRISC/siRISC then cleaves the mRNA (EsquelaKerscher and Slack 2006). Because the products of cleavage are not protected by a 5’ mG cap or
3’ poly-A tail, they degrade in the cytoplasm. The miRISC/siRISCs are therefore recyclable
catalysts and continue to bind to additional mRNA targets. Small amounts of miRNA/siRNA
can have a dramatic effect in down-regulating or silencing gene expression (Hartwell, Hood et al.
2008).
A translational blockage occurs when the miRISC/siRISC sequence forms an imperfect
hybrid with the mRNA. In this case, the mRNA remains intact and loads into ribosomes.
However, the miRISC/siRISC represses the movement of the ribosomes, leading to the downregulation of translation (Hartwell, Hood et al. 2008).

1.3.2 RNAi-promoted Cell Proliferation and Differentiation
The involvement of miRNAs in the proliferation and differentiation of skeletal muscle
was demonstrated by Chen et al. Their findings presented evidence that the studied miRNAs
acted as post-transcriptional repressors that controlled myogenesis, or the formation of skeletal
muscle tissue (Chen, Mandel et al. 2006). Specifically, miR-1 was found to induce the
expression of myogenic markers in cells that were proliferated in the log-phase of growth. These
markers resulted in accelerated myogenic differentiation. Another miRNA, miR-133, was found
to promote myoblast proliferation. The interplay between the proliferation and differentiation of
5

myoblasts, the precursors of skeletal muscle, plays a key role in the regenerative growth of
skeletal muscle tissue.
With the establishment of the involvement of miRNAs in muscle tissue growth, Rhim et
al. found that the transient inhibition of miRNAs would enable the finely tuned regulation of cell
differentiation that is needed for the successful growth of musculoskeletal tissue in vitro (Rhim,
Lowell et al. 2007). The approach to developing a control strategy for directed cell
differentiation is therefore focused on delivering siRNAs to silence either mRNA or miRNA at
varying times and spatial locations.
A couple strategies to accomplish spatial and temporal control of RNA molecules have
been employed in recent work, primarily based on the use of external triggers. One method
exerts remote electronic control over the hybridization of DNA molecules through inductive
coupling a radio-frequency magnetic field to a metal nanocrystal antenna covalently linked to a
DNA oligonucleotide (Hamad-Schifferli, Schwartz et al. 2002). The external trigger technique
investigated in this work utilizes chromophores to optically trigger biomolecular activity in a
field known as photocage chemistry.

1.4

Photochemistry and Cage Compounds

1.4.1 Caging via Photochemistry
In addition to the need for transient gene silencing for optimal proliferation and
differentiation of myoblasts, flooding an organism with active siRNAs would be unsafe. The
downstream effects of widespread gene silencing that could occur in off-target tissues would
have unpredictable results. The chosen approach to achieve spatiotemporal control of siRNA
6

molecules is to utilize a photolabile protecting group known as a “cage” (Givens, Kotala et al.
2005).
Caging specifically describes the attachment of a photolytic chromophore for the prompt
release of a biologically active substrate (Kaplan, Forbush et al. 1978). By covalently alkylating
an isolated nucleic acid with a photolabile cage, the bioactivity of the nucleic acid is blocked.
Upon exposure to the appropriate wavelength of light (Figure 2), the caging group photocleaves
and restores the nucleic acid to its original bioactive state (Casey, Blidner et al. 2009), thus
enabling a system of control over the location and timing of the siRNA activity. Finer control is
achieved by varying the location, intensity, and duration of the light pulse delivered to uncage
the molecule of interest (Givens, Kotala et al. 2005). No further photoactivation occurs in the
absence of light, so the delivery of light in a step function technique will allow for the controlled
activation of nucleic acids, only activating a portion of the siRNAs at a time (Casey, Blidner et
al. 2009).

Figure 2 – Caged siRNA
Caged siRNA is biologically inactive until UV light exposure cleaves the cage moieties, enabling
initiation of gene silencing (Casey, Blidner et al. 2009).
Photocaging offers advantages for the delivery of siRNAs by allowing the dispersal of
the biologically inert siRNAs with minimized risk of initiating gene silencing in off-target
tissues. Caged siRNAs could conceivably be introduced intravenously for activation in a
specific location of interest. Therefore, the photocaged siRNAs offer a major advantage over
conventional delivery methods of gene silencing (Givens, Weber et al. 1998). However, the
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photocaging process is not always perfect; small amounts of “leak,” or bioactivity in the nonphotolyzed state, could lead to gene silencing in unintended tissues and have an effect on study
results (Casey, Blidner et al. 2009).
Caged nucleic acids were first demonstrated in vitro and in vivo for photoinduced control
of gene expression in 1999 (Monroe, McQuain et al. 1999). Two classifications of caged nucleic
acid molecules have emerged: those that were caged using a random method termed “statistical
caging” (Mayer and Heckel 2006), and more recent site specific approaches to photocage
predetermined sites on knockdown oligonucleotides (Casey, Blidner et al. 2009). Statistical
caging, also known as bulk caging, uses a batch-style reaction to attach the cage molecule to the
phosphate backbone using diazo attachment chemistry (Walker, Reid et al. 1988; Monroe,
McQuain et al. 1999; Casey, Blidner et al. 2009). Limitations of this method include significant
leak activity (Shah, Rangarajan et al. 2005) and evidence of a 2′-hydroxyl attack at the
phosphotriester backbone (Breslow and Xu 1993). Further in-depth review of caged nucleic
acids is offered by Casey et al. (Casey, Blidner et al. 2009).

1.4.2 Cage Compounds
A variety of cage compounds have been studied since 2-nitrobenzyl was used to cage
ATP (Kaplan, Forbush et al. 1978). Success as a cage compound requires ease of synthesis of
the effector-cage complex and efficiency of photochemical release of the effector (Givens,
Kotala et al. 2005). Based on these criteria, only four categories of cage compounds are
currently considered robust enough for use: (1) 2-nitrobenzyl (2-NB), (2) benzoin, (3) phydroxyphenacyl, and (4) arylmethyl derivatives including the benzyl and coumaryl
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chromophores (Givens, Kotala et al. 2005). The chemical structures of several photocaging
groups are shown in Figure 3.

Figure 3 – Common cage compounds for use with siRNAs
X = substrate, NB = nitrobenzyl, DMNB = dimethoxy-nitrobenzyl, NPP = nitrophenylpropyl,
NPE = nitrophenylethyl, DMNPE = dimethoxy-nitrophenylethyl, NPOM = 6nitropiperonyloxymethyl, pHP = p-hydroxyphenacyl (Casey, Blidner et al. 2009).

The best characterized and most widely utilized cage molecules come from the 2-nitrobenzyl
group and its derivatives (Casey, Blidner et al. 2009). More in-depth reviews of cage
compounds are offered by Givens and Casey (Givens, Kotala et al. 2005; Casey, Blidner et al.
2009).
For this work, 2-nitrobenzyl was selected due to its robust properties as a cage molecule
and its ease of attachment in synthesis reactions. In addition, 2-nitrobenzyl groups exhibit
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reliably high photorelease efficiencies due to the irreversible photoredox mechanism shown in
Figure 4 (Givens, Kotala et al. 2005).

Figure 4 – General mechanism for 2-nitrobenzyl photorelease of a substrate.
X = substrate. Rate constants are: kST = single-triplet crossing; kH = hydrogen abstraction; kcyc =
cyclization to the isoxazole; kH2O = direct hydrolysis to the isoxazole; kfrag = fragmentation of the
isoxazole; khemi = hemiacetal or ketal hydrolysis. Intermediate states are labeled a, b, and c.
Adapted from (Givens, Kotala et al. 2005).

1.4.3 Convertible Nucleoside Approach
One method to obtain photolabile protecting groups on the nucleobase is the postsynthesis substitution of the oligonucleotide. A group led by Verdine developed a method for
incorporating reactive nucleotide analogs with protecting groups stable under the conditions of
RNA solid-phase synthesis, but able to undergo substitution for post-synthetic placement of the
cage compound. They named their technique “the convertible nucleoside approach” (Ferentz
and Verdine 1992; Ferentz, Keating et al. 1993). This method offers an advantage over the site10

specific modified phosphoramidite approach in which the 2′-hydroxyl of RNA is caged (Chaulk
and MacMillan 2007). Although the caged adenosine phosphoramidite is easily incorporated
into short oligonucleotides by automated synthesis, the protected adenosine requires an extensive
synthesis procedure (Chaulk and MacMillan 2007; Casey, Blidner et al. 2009). In contrast, the
photoprotecting synthesis through the convertible nucleoside approach is much simpler and
requires fewer reagents. The cage compound conversion reaction requires a primary amine that
is nucleophilic in order to undergo nucleophilic aromatic substitution, shown in Figure 5
(Allerson, Chen et al. 1997).

Figure 5 – Amine Substitution of Adenosine Nucleoside
Generalization of the reaction to alkylate convertible adenosine nucleosides using aminolysis or
nucleophilic aromatic substitution. X = leaving group, R = cage group. (Allerson, Chen et al.
1997).
Using this convertible nucleoside method, Verdine’s group successfully demonstrated the
conversion of a modified adenosine molecule using benzylamine, shown in Figure 6 (Allerson,
Chen et al. 1997). This generated a modification which attached benzylamine to the N6 position
of adenosine. From this synthesis reaction, Blinder developed a similar synthesis procedure to
attach the 2-nitrobenzylamine (NB-NH2) cage molecule to the N6 position of adenosine,
discussed in Section 2.3.1.
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Figure 6 – Convertible Adenosine Reaction
The future implications of this work, together with the convertible nucleoside approach,
will allow for the site-specific
specific photocaging of RNA oligonucleotides. RNA oligos can be

Figure 7 – Convertible adenosine incorporation into RNA oligo
manufactured with a DNA/RNA synthesizer, and the identified adenosine nucleosides can be
substituted for a convertible nucleoside. Synthesis techniques would then be applied to the oligo
to modify the convertible nucleoside into a photocaged adenosine ((Figure 7).
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1.5

ATP as a Model System for RNA
Adenosine triphosphate (ATP) is widely recognized for its central role in intracellular

energy transfer due to its involvement in cellular control mechanisms and metabolic processes
(Knowles 1980). Caged ATP provides an excellent model for testing caging synthesis protocols.
Historically, caged ATP was one of the first examples of the application of photochemistry to
exert control over the biological activity of a substrate (Kaplan, Forbush et al. 1978; Blidner
2007). In the first study by Kaplan, 2-nitrobenzyl and 1-(2-nitrophenyl)ethyl groups were
attached to the gamma phosphate of ATP to control the activity of a Na:K ATPase ion pump
(Kaplan, Forbush et al. 1978). Since then, caged ATP has been used for a myriad of
applications, especially for kinetic studies of ATP-dependent enzymatic studies including the
Na,K-ATPase pump (Kaplan, Forbush et al. 1978; Forbush 1984; Geibel, Barth et al. 2000),
transport by the mitochondrial ADP/ATP carrier (AAC) (Broustovetsky, Bamberg et al. 1997;
Gropp, Brustovetsky et al. 1999), kinesin (Higuchi, Muto et al. 1997), and myosin/actomyosin
(Thirlwell, Corrie et al. 1994). Many of these applications utilize the nitrobenzyl cage group
with γNPE caged ATP (Kaplan, Forbush et al. 1978; Forbush 1984; Broustovetsky, Bamberg et
al. 1997; Higuchi, Muto et al. 1997; Gropp, Brustovetsky et al. 1999). Other studies have used
other cage molecules, such as DMB-caged ATP (Thirlwell, Corrie et al. 1994) and pHP-caged
ATP (Geibel, Barth et al. 2000).
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Figure 8 – Structures of (a) chain
chain-form adenosine in RNA, (b) adenosine-5'--triphosphate
In addition to the ubiquitous application of ATP in enzymatic assays, ATP can be used as
a model for the adenosine nucleotide in RNA due to the inherent similarity of structure, shown in
Figure 8.. This structural similarity will allow similar synthesis techniques to be conducted on
ATP analogs and adenosine convertible nucleosides.

1.5.1 Gamma-Phosphate
Phosphate Caged ATP
Traditional caging of ATP has been achie
achieved
ved via the alkylation of the gamma phosphate.
Although the γ-phosphate
phosphate caged ATP does inhibit kinase activity, protein
protein-ATP
ATP binding has been
reported to occur regardless of the cage status. This interference of caged ATP in an enzymatic
system was first identified by Forbush with the discovery that ATP, caged at the γ-phosphate,
binds to Na+:K+-ATPase
ATPase with a greater affinity than uncaged ATP (Forbush 1984).
1984) This caused
unphotolyzed caged ATP to occupy the catalytic sites of the Na+ pumps prior to the photolysis
pho
flash. Forbush found that most of the free ATP is produced in solution while only about 2% of
the bound caged ATP converted to ATP (Forbush 1984).. Consequently, ATP caged at the γphosphate competitively inhibits the Na+:K+-ATPase pump.

14

The competitive inhibition of ATP binding by NPE γ-phosphate caged ATP was further
observed in other enzymatic systems. Thirlwell et al. found evidence indicative of inhibition in
the relaxation of muscle fibers with actomyosin ATPase (Thirlwell, Corrie et al. 1994). Caged
ATP was also found to inhibit ATP-driven sliding of kinesin and microtubules in motility assays
(Higuchi, Muto et al. 1997). Competition between caged and free ATP in mitochondrial
ADP/ATP carrier protein studies indicated that the caged form had stronger affinity with the
protein binding site than native ATP (Broustovetsky, Bamberg et al. 1997). The competitive
inhibition is not limited to the 2-NB and NPE cage molecules in the γ-phosphate caged ATP; the
Na+:K+-ATPase also undergoes competition with p-hydroxyphenacyl (pHP)-caged ATP (Geibel,
Barth et al. 2000). Since many of these enzymatic systems are specific to adenosine
triphosphate, this work strives to cage the adenine nucleobase in order to determine if
competitive inhibition is lessened, while still blocking the bioactivity of ATP. Caging the
adenine nucleobase at the N6 position, using the convertible alkylation schemes discussed in
Section 1.3.3, may provide spatial-temporal control over the biological activity of ATP without
engaging in the competitive inhibition of free ATP. Although recent work has resulted in
advances in nucleobase caging of oligonucleotides (Hobartner and Silverman 2005), synthesis of
base-caged ATP had not been investigated until recently (Blidner 2007).

1.5.2 Enzymatic Binding of ATP and Base-Caged ATP Hypothesis
For this work, a luciferin/luciferase ATP reporter assay was selected as the in vitro
system for studying caged ATP due to its well-characterized linear response and inherent
hydrolysis of ATP. Additionally, luminescence produced by the assay allows for the
quantification of native ATP, caged ATP, and photolyzed ATP species.
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Support for caging the N6 position of ATP comes from literature describing the molecular
binding of ATP to proteins and enzymes. For example, firefly luciferase has a long history of
biochemistry and kinetic studies, including the determination of the ATP binding site. As long
ago as 1970, Lee, Denburg, and McElroy found the 6-amino group of adenine to be critical for
the adenylate intermediate binding required to produce the luciferase luminescence (Lee,
Denburg et al. 1970). They also found that the energetic contributions to ATP-luciferase binding
come from the adenine ring and the α phosphate group. These findings implicate the N6 ATP
group as a key player in ATP-luciferase binding.
Twenty-six years later, firefly luciferase was the first enzyme of its class to be
crystallographically characterized, further elucidating the structures of the adenylate-forming
enzyme superfamily (Conti, Franks et al. 1996). The crystal structure supported the theory that
luciferase correctly positions and stabilizes binding of ATP for catalyzing adenylate formation,
beginning the cascade to produce luminescence. A more recent study used the Protein Data
Bank to mine for molecular recognition of the adenine moiety of ATP by proteins (Mao, Wang
et al. 2004). They found that nearly 59% of adenylate-protein complexes involve the N1 and N6
atoms of the adenine base via the formation of dual hydrogen bonds, and hydrogen bond
formation was even higher (85%) for the N6 position overall.
Based on the review of ATP binding in literature, we hypothesize that blocking access to
the 6-amino group via cage molecule will prevent the initial enzyme-substrate binding event
from occurring prior to photolysis, effectively minimizing competitive inhibition. This
hypothesis is depicted schematically in Figure 9.
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Figure 9 – N6 caged ATP (BC-ATP)
ATP) Hypothesis
A. Schematic representation
presentation of ATP hydrolysis by luciferin/luciferase: the enzyme nucleotide
binding domain (NBD) binds ATP at the adenosine. B. Following hydrolysis, the enzyme
releases AMP and pyrophosphate. C. Enzyme binds γNPE-ATP
ATP at the adenosine, but hydrolysis
iss blocked by the cage molecule. D. Location of cage molecule attachment on proposed basebase
6
caged ATP. E. Hypothesis: attachment of cage molecule to N of adenosine prevents binding to
NBD of enzyme, therefore preventing competitive inhibition.
The ATP binding site of the enzyme is designated here as the nucleotide binding domain
(NBD), but it is alternatively referred to as the adenylate binding site.
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CHAPTER 2 – EXPERIMENTAL DESIGN
2.1

Previous Work
Investigation of base-caged ATP was previously conducted by Rick Blidner as part of his

dissertation research in the Biological & Agricultural Engineering Department at Louisiana State
University (Blidner 2007). The continuance of his work is prompted by the promising results
indicated by a luciferase ATP assay (Table 1), in which enzyme activity (measured as
luminescence) was documented prior to and following photoexposure using ATP, 1-(2nitrophenyl)ethyl (NPE) γ-phosphate caged ATP, and 2-nitrobenzylamine (NB-NH2) base-caged
ATP (Blidner unpublished data). The base-caged ATP products were synthesized using the
modified nucleoside technique mentioned in Section 1.4.3. Both caged ATP analogues
demonstrated photoactivation, and NB-NH2 base-caged ATP exhibited greater caging efficacy
than NPE γ-phosphate-caged ATP as seen by the incomplete suppression of bioactivity while
caged, or leak activity, of γ-phosphate NPE caged ATP. The crude base-caged ATP products
could be tested without purification because the unreacted 6-chloropurine riboside triphosphate
(CPR-TP) has negligible activity in the luciferase reporter assay. The results in Table 1 used a
final ATP concentration of 10 µM, within the predetermined linear range of the assay, as
described in more detail in Section 2.3.5 (Blidner 2007).
Table 1 – Luciferase ATP assay with caged effectors
Before UVA
light exposure
(RLU)
7852 ± 438
295 ± 13
1 ± 1.3
6 ± 10.9

Sample
ATP [10 µM]
γNPE-caged ATP [10 µM]
Base-caged ATP [10 µM] *
Unreacted CPR-TP [10 µM]

After UVA light
exposure (RLU)
N/A
5623 ± 394
4958 ± 266
N/A

*Crude, unpurified product (Blidner unpublished work)
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The caged ATP species were co-incubated with free ATP (10 µM final concentrations, 50
µL) to evaluate competitive inhibition. The percentages of ATP activity of the co-incubations,
relative to an ATP standard plus buffer that was run in parallel, are shown in Table 2. The γphosphate caged ATP reduced the observed luminescent signal, indicating competitive
inhibition. Conversely, no statistical difference could be drawn between the free ATP standard
and the co-incubation of ATP with base-caged ATP (Blidner 2007).
Table 2 – % of RLU from ATP co-incubated with caged effectors
Sample
ATP alone [10 µM]
ATP [10 µM] + γNPE-caged ATP [10 µM]
ATP [10 µM] + base-caged ATP [10 µM]

2-nitrobenzyl
100.0% ± 32.0%
† 23.0% ± 9.0%
‡ 128.1% ± 12.6%

Symbol † denotes statistical difference between caged-ATP and ATP standard
Symbol ‡ denotes statistical difference between γ-phosphate and base caged ATP
(Student's t-test p < 0.05) (Blidner unpublished work)

The results in Table 1 and Table 2 provided support for continuing this work to obtain
purified products for characterization and publishable data.

2.2

Experimental Design
This project sought to develop a precise photocaging synthesis process, utilizing base-

caged ATP as a model system for caged RNA. As mentioned above, preliminary data suggested
that base-caged ATP does exhibit the desired characteristics of bioactivity. However, this data
was obtained from crude products without purification or structural characterization. Key issues
with the previous protocol included the formation of a triethylammonium salt during the caging
synthesis, which proved difficult to remove from the product mixture. Another significant
challenge in the prior work was the purification of the caged ATP in order to accurately
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characterize the results. Various separation procedures through column chromatography and
HPLC were utilized to effectively purify the base-caged ATP. Finally, purified base-caged ATP
was utilized to demonstrate caging efficacy and comparative competitive inhibition behavior in a
luciferase reporter assay. The experimental design is shown graphically in Figure 10.

Synthesis and
Purification

Characterization of
BC-ATP

• Refine synthesis and
purification protocol
• Extraction
• Removal of salts,
impurities, other byproducts

• UV/Visible
Spectrophotometry
• HPLC
• NMR
• Mass Spectrometry

Demonstration
• Bioactivity inhibited in
base-caged form
• Photolysis restores
bioactivity
• Base-caged ATP does not
interfere in enzymatic
systems

Figure 10 – Project Overview

2.3

Materials and Methods

2.3.1 Base-caged ATP Synthesis
2-nitrobenzylamine (NB-NH2), triethylamine (TEA), and 6-chloropurine riboside (CPR)
were purchased from Sigma Aldrich (St. Louis, MO). 6-Chloropurine riboside-5’-triphosphate
(CPR-TP) was purchased from Trilink Biotechnologies (San Diego, CA). TEA is utilized in this
organic synthesis as a base, because the nucleophilic aromatic substitution reaction leads to the
production of hydrogen chloride (Paquette 2009). The HCl combines with TEA to form
triethylammonium chloride, and therefore allows the reaction to proceed to completion upon
removal of the hydrogen chloride.
20

The reaction mixture for synthesizing base-caged ATP was first prepared by dissolving
NB-NH2 (0.040 g) in methanol (150-400 µL) by heating to 60˚C in a water bath. Triethylamine
(50 µL) was added to the reaction mixture, along with CPR-TP (1 µmole). Once combined, the
reaction mixture was rocked and incubated at 50˚C for 24 hours in a water bath shaker. The
reaction scheme is shown in Figure 11.

Figure 11 – Synthesis Scheme for Base-Caged ATP
Nitrobenzylamine is dissolved in methanol, and then CPR-TP and triethylamine are added to the
reaction mixture. The mixture is rocked and incubated at 50°C for 24 to 28 hours to produce
base-caged ATP.

2.3.2 Extraction and Purification
Upon completion of the synthesis, excess NB-NH2 was separated from the other reaction
substituents via liquid-liquid extraction. Dichloromethane (DCM) (MW = 84.93 g/mol, 100 µL)
and deionized water (100 µL) were added to the solution and mixed by shaking. The solution
was briefly centrifuged, and the aqueous layer was collected. The extraction was repeated twice
more with 100 µL of DCM. If chemical analysis indicated that NB-NH2 remained in the aqueous
layer, the liquid-liquid extraction was repeated.
Sodium bicarbonate was then added to the reaction mixture to dissociate the
triethylammonium chloride and allow for its removal from the reaction mixture as
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triethylammonium bicarbonate (TEAB). The resulting sodium bicarbonate mixture was dried in
vacuo, re-suspended in methanol and processed via silica gel column chromatography. The
sodium bicarbonate was retained by the column and allowed for the separation of base-caged
ATP from salt contaminants. Samples were stored at 4˚C and protected from light.

2.3.3 Photolysis
Caged compounds are commonly activated by short, intense exposures to wavelengths of
light in the UVA range (315–400 nm) (Forman, Dietrich et al. 2007). Commonly, electrondonating ring substitutions on cage compounds result in a hyperchromatic absorbance shift, or an
increase in energy absorbance. This allows photolysis to occur at longer wavelengths that are
less damaging to cells or other biological systems (Casey, Blidner et al. 2009).
For this work, photolysis was conducted via transilluminator (TFM-20, UVP Inc.,
Upland, CA). The transilluminator was used to photolyze BC-ATP and γ-NPE caged ATP
samples in 200 µL thin walled PCR Eppendorf tubes at a UVB wavelength of 308 nm with an
irradiance of 6.5 mW/cm2 (Blidner 2007). The total light delivered was 60 J/cm2. For these in
vitro experiments, negligible photoeffects of 308 nm exposure were observed, though

Figure 12 – Photolysis Scheme
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this wavelength would have damaging photoeffects in vivo (Forman, Dietrich et al. 2007). The
photolysis scheme is represented in Figure 12.
The quantum yield of the radiation-induced photolysis is the number of caged ATP that
photolyze to become free ATP molecules per photon absorbed by the system: Φ = # reactant
molecules decomposed / # photons absorbed. The quantum yield of base-caged ATP was
determined enzymatically (see Section 2.3.5) by stepping through several time points in
photolyzing the caged ATP. Both base-caged ATP and γNPE-caged ATP were photolyzed in
this method to determine which caging strategy had the most efficient photolysis.

2.3.4 Characterization
2.3.4.1

UV/Vis Spectrophotometry
Throughout the project, several spectroscopy techniques were used to determine the

compositions of samples and evaluate the synthesis and purification of base-caged ATP.
Spectrophotometry has been widely used to characterize the absorbance spectra of caged
nucleotides and their photoproducts (Walker, Reid et al. 1988). Spectrophotometry of the
products and reactants was conducted in the visible and UV range using the Spectronic
GENESYS 6 UV-Visible Spectrophotometer (Thermo Scientific) and the spectrophotometer
built into the HPLC (Dionex).
2.3.4.2

HPLC
The processed base-caged ATP was analyzed via reverse-phase HPLC (Dionex) on a C18

column at a flow rate of 0.4 mL/min with the solvent conditions shown in Figure 13.
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HPLC Solvent Profile
A - 0.1% TFA in diH2O
B - 0.1% TFA in Acetonitrile
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Figure 13 – HPLC reverse phase solvent conditions.
A-0.1% trifluoroacetic acid (TFA) in diH2O and B-0.1% trifluoroacetic acid (TFA) in
acetonitrile.

2.3.4.3

Nuclear Magnetic Resonance Spectroscopy
Nuclear magnetic resonance (NMR) spectroscopy was conducted using 1H (proton)

signals. The solvent for analysis was 100% deuterium oxide (D2O). Samples were dissolved in
600 µL D2O and transferred to the NMR tubes. The NMR spectroscopy was conducted using the
Bruker AV-400 in the LSU Chemistry Department NMR facility.

2.3.4.4

Mass Spectrometry
Products purified through HPLC and column chromatography were analyzed through

electrospray ionization mass spectrometry (ESI-MS) to verify their molecular weights. ESI-MS
(negative ion mode) was conducted externally through the LSU Chemistry Department’s Agilent
6210 spectrometer.
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2.3.5 Enzymatic Demonstration
Base-caged ATP was evaluated in an enzymatic assay to determine the degree of
bioactivity in the caged and photoactivated states. As discussed in Section 2.2, it was important
to study the inhibited bioactivity of ATP in base-caged form, the efficacy of photolysis in the
restoration of bioactivity, and competitive inhibition of base-caged ATP relative to the known
inhibitory moieties in enzymatic systems. Both base-caged ATP and γNPE-caged ATP were coincubated with native ATP, and the experiments were run in parallel to determine the properties
of competitive inhibition.
An ENLITEN® ATP Assay System (Promega, Madison, WI) was utilized to
quantitatively detect the biological activity of photolyzed base-caged ATP and analyze
competitive inhibition in comparison. Native ATP and γ-NPE ATP were utilized for positive
controls. rLuciferase/Luciferin (rL/L) reagent was reconstituted according to the manufacturer’s
instructions. The assay was conducted via Wallac 1420 Multilabel Counter (PerkinElmer,
Waltham, MA) in the LSU AgCenter Biotechnology Laboratory (ABL). The Wallac dispenser
unit provided automated rL/L addition to the samples on a 96-well white opaque plate, and
luminescence was measured in RLUs (relative luminescence unit).
ATP is required for the oxidation of luciferin, which produces luminescence when ATP is
hydrolyzed. In the range of 10-8 to 10-6 M ATP, luminescence of the luciferase assay increases
linearly with ATP concentration (Geibel, Barth et al. 2000). ATP concentrations within this
range were determined through luminescence measurements. The standard curve for the
luciferase assay was established for each run with the luminometer due to the significant
variance in luminescence according to temperature and time of storage. The volume of the ATP
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standard was small in order for the reaction to favor the forward direction and give accurate RLU
output (Lundin 2000). As a standard, 5 µL of ATP solutions (10-6, 10-7, 10-8 M ATP in purified
water) were mixed with 60 µL of ATP-free water, 10 µL aliquots of luciferase assay solution
were automatically injected by the plate reader, and the luminescence was determined (Geibel,
Barth et al. 2000). The light emission due to the ATP standard was used to calculate the ratio
between RLU and ATP concentration. To verify base-caged ATP concentration as determined
by UV/Visible spectrophotometry measurement, 5 µL of the photolyzed base-caged ATP sample
solution was mixed with the same ATP-free water and luciferase assay solution volumes, and the
luminescence was determined.
The co-incubation experiments required a different protocol using the luminometer. The
initial protocol evaluating the competitive inhibition of native ATP by caged ATP species
utilized the protocol above, with 5 µL sample volumes, 60 µL of ATP-free water to ensure
coverage of the well, 10 µL aliquots of luciferase assay solution were automatically injected into
the programmed wells, and after shaking for 1 second, the luminescence readings were taken.
After optimization for maximum competitive inhibition of native ATP luminescence by γ-NPE
ATP, 7.5 µL of ATP standards were used with 7.5 µL of ATP-free water, and the co-incubations
were set up using 7.5 µL of caged ATP plus 7.5 µL of native ATP, 100 uM initial
concentrations. The luciferin/luciferase solution was diluted to 1:100 and the injection volume
was increased to 60 µL, for a final concentration of 10 uM of each species. Once the
luciferin/luciferase solution was injected, the plate was shaken for 3 seconds and the
luminescence readings were taken.
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CHAPTER 3 – RESULTS
3.1

Characterization

3.1.1 UV/Vis Spectrophotometry
Initial characterization of BC
BC-ATP was based on UV/Visible
ible spectrophotometry and
direct mass spectrometry of the purified product. Base
Base-caged
caged ATP has a UV/visible absorbance
spectrum that is not only distinct from the primary reactants CPR
CPR-TP, NB-NH2, and TEA, but is
also very similar to γ-NPE
NPE ATP ((Figure 14). The photolyzed BC-ATP
ATP spectrum closely
correlates to native ATP. Notably, photolyzed BC
BC-ATP
ATP and native ATP share a local absorbance
maximum at 259 nm, while
ile the peak for caged BC
BC-ATP
ATP is red shifted to 268 nm.

Figure 14 – UV/Visible absorbance spectra.
A. Spectra of native ATP, initial reactant CPR
CPR-TP, base-caged
caged ATP, photolyzed BC-ATP,
BC
γNPE caged ATP, and photolyzed γ-NPE ATP.
TP. B. Comparison of reaction materials spectra –
CPR-TP, NB-NH2, TEA – and final product BC
BC-ATP.
ATP. C. Comparison of caged species spectra
with native ATP. D. Comparison of photolyzed species spectra with native ATP.
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The concentration of BC-ATP was determined indirectly by UV/visible absorbance
spectral data. A standard absorbance curve was developed using the known mass, volume, and
structure of γ-NPE ATP, from which the concentration of BC-ATP was extrapolated. The
extrapolated concentration was then confirmed with luciferase luminescence data that was
statistically equivalent for photolyzed BC-ATP and γ-NPE ATP receiving the same irradiance.
The absorbance peaks for the associated molecules are shown in Table 3.

Table 3 – UV/Vis Absorbance Peaks
Molecule
Native ATP
CPR-TP
Base-caged ATP
γNPE caged ATP
NB-NH2

Absorbance Peak (nm)
258 – 260 a
262 b
260 – 265
259 – 261 a
220, 260

Absorbance peaks provided by a Sigma-Aldrich, b TriLink BioTechnologies.

3.1.2 Mass Spectrometry
Mass spectral analysis using negative ion mode MS-ESI was successful in identifying the
target base-caged ATP. The mass spectrometry results yielded an exact mass m/z of 641.02,
corresponding to the elemental composition of C17H21N6O15P3 within 0.01 ppm (theoretical m/z
641.03). Also seen in the mass spectrum were values corresponding to base-caged adenosine
diphosphate (m/z 561.05). In both caged and photolyzed base-caged ATP sample, native ATP
was identified at m/z = 505.98, indicating photolysis occurred despite protecting BC-ATP from
light. These molecular structures and their exact masses are shown in Figure 15, and the mass
spectrum of base-caged ATP is shown in Figure 16.
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Figure 15 – Exact Masses for A. Base
Base-caged ATP, B. Base-caged
caged adenosine diphosphate, C.
Native ATP

Figure 16 – Mass Spectrum of BC
BC-ATP: A. Base-caged ATP, B. base-caged
caged adenosine
diphosphate, C. native ATP.
The electrospray ionization conditions applied to base
base-caged
caged ATP during mass spectral
analysis can lead to the uncaging of the molecule. In addition, some of the caged products were
wer
hydrolyzed to base-caged
caged adenosine diphosphate under the ESI conditions. These results do not
necessarily reflect an impure product, but rather the conditions of the analysis.
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3.1.3 HPLC
Chromatographic analysis via HPLC revealed that the elution time of the base-caged
base
ATP more closely followed NB-NH
NH2 rather than native ATP, shown in Figure 17.
17 The primary
signal for BC-ATP
ATP occurred at about 11 minutes, while native ATP eluted from the column at
about 5 minutes. The chromatograms demonstrate the shift in polarity of the caged ATP from

Figure 17 – HPLC Chromatogram of Native ATP, BC
BC-ATP, and NB-NH2 at 260nm and
308nm.
native ATP due to the addition of the nitrobenzylamine cage molecule. Closer inspection of the
caged and flashed BC-ATP
ATP chromatograms revealed important trends. Figure 18 clearly shows
the absence of the native ATP pea
peak for base-caged
caged ATP, while the photolyzed BC-ATP
BC
has the
peak that closely follows the native ATP peak at about 4.6 minutes.
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Figure 18 – HPLC Chromatogram of BC-ATP (caged and flashed) and Native ATP at
260nm
The chromatogram for the 308nm detector is shown in Figure 19. Here, the flashed BCATP closely follows the native ATP signal. During the course of the HPLC analyses, it was
discovered that the native ATP peak integration actually decreased with increased photolyzation
time. This was detected by studying the elution peak integration trends shown in Figure 20.

Figure 19 – HPLC Chromatogram of BC-ATP (caged and flashed) and Native ATP at
308nm
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Figure 20 – HPLC Peak Integrations at 260nm
The elution peak integration trends show that increased photolyzation time led to the
possible degradation of base-caged ATP into an adenosine product. The identity of the
adenosine product was confirmed by liquid chromatography–mass spectrometry (LC-MS)
conducted under the same HPLC conditions, shown in Figure 21 and Figure 22.

Figure 21 – LC-MS Chromatogram Highlighting Free Adenosine
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Figure 22 – LC-MS Chromatogram Highlighting Caged Adenosine
Although LC-MS was conducted on a slightly different reaction product, the overlapping
elution time highly suggests that either free adenosine or caged adenosine elute from the flashed
BC-ATP column at 16.6 minutes. Therefore, referring back to Figure 20, it is likely that the
continued photolysis of base-caged ATP at a wavelength of 308nm led to the degradation and
loss of phosphate groups. Shorter photolysis time and a longer, lower energy wavelength UV
light may resolve this degradation issue in the future.

3.1.4 Nuclear Magnetic Resonance Spectroscopy
To provide further evidence of the proposed BC-ATP structure we sought to analyze it by
NMR spectroscopy. Purification of the sample was unable to fully separate triethylamine from
the base-caged ATP despite many attempts to separate the two species (Figure 23). However,
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Figure 23 – 1H NMR Spectrum for BC
BC-ATP triethylammonium salt.
The spectrum is dominated by triethylammonium salt in the sample.
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ATP analogues are often supplied as triethylammonium salts, so this association is not expected
to have a significant impact on biological performance (Google search “atp triethylammonium
salt”). Additionally, triethylamine has been utilized in caged ATP synthesis since the beginning
of its existence (Kaplan, Forbush et al. 1978).

Although the N6 proton of adenosine would structurally appear to be a good indicator of
cage status for base-caged ATP, its signal is too difficult to predict or identify on the NMR
spectrum. Instead, the -CH2 protons on the carbon between the nitrobenzyl group and ATP were

Figure 25 – 1H NMR Spectrum of BC-ATP in D2O.
Inspection of the spectrum reveals the expected base-caged ATP signals. Most notable is the
strong signal at approximately 4.5 which closely corresponds to the expected signal from the CH2 protons at carbon 11.
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used as markers to evaluate the sample compositions as shown by the predicted NMR spectra
shown in Figure 24. This proton location is designated “H11” in Figure 25.
Analysis of the “zoomed-in” NMR spectrum of base-caged ATP (Figure 25) reveals the
signal pattern that closely corresponds to the expected proton shifts in Figure 24. Most notable
is the strong signal at approximately 4.5 which closely corresponds to the expected signal from
the -CH2 protons. The ribose, purine, and benzyl protons are also distinct and exhibit the
expected shifts. Native ATP and the photolysis product 2-nitrosobenzaldehyde are not
detectable in the sample as determined by the lack of signals at 6.99 and 10.36 ppm, respectively.

3.2

Enzymatic Demonstration – Luciferase Assay
The recombinant firefly luciferase assay was utilized initially to validate the

quantification of base-caged ATP, and then to evaluate its biological activity performance prior
to and following photolysis. Due to the inherent variability of the luciferase assay, all data are
normalized according to ATP standards run with each experiment as per supplier specifications.
As shown in Figure 26, base-caged ATP demonstrated caged and photolyzed luminescence that
is comparable to γ-NPE ATP. However, caged BC-ATP showed a 3.11% level of leak that could
be attributed to processing without buffer solution. This is a statistically significant difference
from the leak exhibited by γ-NPE ATP (P < 0.001). It is also important to note that the BC-ATP
precursor reactant CPR-TP has negligible luminescence, indicating that the initial ATP analog
compound has no biological activity.
Both caged and photolyzed samples of BC-ATP and γ-NPE ATP were co-incubated with
native ATP to evaluate the competitive inhibition of luminescence activity of native ATP by the
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Figure 26 – Luciferase Reporter Assay for Caged vs Flashed ATP
Normalized relative luminescence units (RLUs) comparison of BC-ATP, γ-NPE ATP and CPRTP. Caged BC-ATP shows a 3.11% leak. Photolyzed BC-ATP and γ-NPE ATP show
statistically equivalent luminescence. CPR-TP exhibits negligible luminescence.
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Figure 27 – Evaluation of Competitive Inhibition with Co-incubations of Caged ATP and
Native ATP.
All species 10 µM final concentrations. Native ATP was competitively inhibited by γ-NPE
caged-ATP by 22% (or 78% luminescence). No inhibition was observed for the co-incubation of
native ATP with base-caged ATP.
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caged molecules. First, the luciferase assay was optimized using native ATP and γ-NPE cagedATP co-incubations to establish the conditions under which competitive inhibition was greatest.
The resulting protocol with 10 µM final concentrations was outlined in Section 2.3.5. The
maximum repeatable competitive inhibition of native ATP by caged γ-NPE ATP was 78%
luminescence, or 22% inhibition of native ATP in solution, seen in Figure 27. The coincubation of native ATP with base-caged ATP shows some leak luminescence, but no
competitive inhibition. The flashed co-incubations for BC-ATP and γ-NPE ATP were
statistically equivalent (data not shown).
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CHAPTER 4 – DISCUSSION
In summary, we have characterized a novel form of photocaged ATP by attaching the
cage molecule to the N6 position of adenosine, and we have demonstrated that it exhibits activity
as a photocaged substrate. First, the base-caged ATP shows 3.11% luminescence activity in the
uninduced form and, upon exposure to 308 nm radiation, the biological activity of ATP is
restored to a level of luminescence statistically equivalent to that of photolyzed γ-NPE ATP.
Secondly, the utilization of base-caged ATP results in significant improvement in
competitive inhibition with native ATP in powering an enzymatic system. The chief problem of
competitive inhibition by the standard γ-NPE ATP in a variety of enzymatic studies, as discussed
in Section 1.5.1, may be largely resolved with base-caged ATP. While γ-NPE ATP in solution
with native ATP results in an average of 22% inhibition, base-caged ATP exhibits no such
competitive inhibition. Further research into the kinetics of base-caged ATP- and photolyzed
BC-ATP-binding to an enzymatic molecule is required before an exact comparison can be made
to the examples of competitive inhibition seen in literature (Forbush 1984; Sleep, Herrmann et al.
1994; Thirlwell, Corrie et al. 1994; Thirlwell, Sleep et al. 1995; Broustovetsky, Bamberg et al.
1997; Higuchi, Muto et al. 1997). These studies characterized the competitive inhibition seen
Table 4 – Inhibitor Dissociation Constants for γ-NPE ATP
Investigator

System

Ki

Thirlwell et al. 1994

actomyosin ATPase

1-2mM

Sleep et al. 1994

myofibrils and actomyosin
subfragment 1
kinesin and microtubules

1.6-1.8mM

Higuchi et al. 1997
Broustovetsky et al. 1997

mitochondrial ADP/ATP
carrier (AAC)
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1.5 mM
5 µM

with γ-NPE ATP by determining Ki, the dissociation constant for the inhibitor. The inhibitor
dissociation constants for studies utilizing γ-NPE ATP are shown in Table 4.
In addition to the synthesis and characterization of this novel photocaged ATP species,
the enzymatic results support the hypothesis that alkylating the N6 position of ATP with the cage
molecule prevents the enzyme-substrate binding from occurring prior to photolysis. Since firefly
luciferase and numerous ATP-dependent enzymes require access to the N6 position for
nucleotide recognition and binding, base-caged ATP effectively blocks the N6 amino proton
from participating in hydrogen-bond binding. The hydrogen-bond obstruction is achieved in two
modes: not only is one of the protons removed in the synthesis of base-caged ATP, reducing the
availability of protons by 50%, but the cage molecule also introduces steric hindrance to prevent
enzyme binding to the remaining N6 proton. By physically blocking the binding of base-caged
ATP to the enzyme, competitive inhibition is eliminated.
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CHAPTER 5 – CONCLUSION
5.1

Conclusion
The synthesis of base-caged ATP yielded a product which was purified and then fully

characterized and confirmed by a combination of analytical chemistry techniques. By caging
ATP at the N6 position of adenosine, biological activity is first prevented in the uninduced form,
and exposure to 308 nm radiation induces the biological activity of ATP, suggesting that a
photocaged form of ATP has indeed been synthesized. In addition, competitive inhibition has
been minimized in the luciferase assay in comparison to γ-NPE ATP. This novel version of
caged ATP should allow for kinetic studies of ATP-dependent enzymatic systems without the
complication of competitive inhibition shown by γ-NPE ATP.

5.2

Implications for Future Work
Beyond kinetic enzymatic studies, base-caged ATP has broad implications for its use in

exerting spatial-temporal control over a substrate. The protocol for synthesizing base-caged
ATP can now be applied to achieve a base-caged oligonucleotide using the convertible
nucleoside approach (Allerson, Chen et al. 1997). This method initially site-specifically
incorporates into RNA synthesis a nucleoside analog with a leaving group on the nucleobase.
The full length RNA is treated with a nucleophile to displace the leaving group and yield the
desired nucleoside with an exocyclically tethered alkylamine, the photolabile cage molecule
(Allerson, Chen et al. 1997). By using the convertible nucleoside method, CPR-TP would be
incorporated into the oligonucleotide in the positions where caged adenosine is desired, and then
the RNA would be treated with 2-nitrobenzylamine to form the caged oligonucleotide. Sites for
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photocaging could then be experimentally optimized in order to determine the minimal number
of cage molecules to prevent leak (incomplete suppression of bioactivity while caged) while
maximizing quantum yield. The quantum yield, or relationship between the required light
energy and the number of bound cage compounds, would then need to be determined for the
caged oligonucleotide. Once this technique is successful, site-specific base-caged
oligonucleotides will be readily available to utilize in such systems as RNA interference with a
base-caged small interfering RNA. A base-caged siRNA would be particularly beneficial in
achieving complex tissue cultures requiring spatio-temporally directed gene knockdown.
More advanced studies would apply base-caged siRNA technology to cellular and in vivo
model systems. One possible study would utilize a cellular model of musculoskeletal
differentiation whereby microRNAs are blocked at certain locations and times with
photoactivatable oligonucleotides, achieving spatial and temporal control in directed tissue
development in vitro. Similarly, caged siRNAs could conceivably be introduced intravenously
for activation in a specific tissue such as an open wound where musculoskeletal cell growth
would be directed by a UV light application programmed for optimized healing. This approach
could also be used to complement cancer therapies by knocking down various oncogenes and
other gene markers associated with poor prognosis.
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APPENDIX A - BASE-CAGED ATP SYNTHESIS PROTOCOL
BC-ATP Reaction
1. Dissolve 0.04 g NBNH2 in 150-400 uL methanol in a reaction tube. Heat using hot plate
if needed.
2. Add 50 uL triethylamine (TEA).
3. Add 16.6 uL of 10mM (1.67 umole) CPR-TP.
4. Rock and incubate overnight (24-28 hours) at 50˚ C.
5. Evaporate MeOH (BP = 64.7 ˚C)
6. Refrigerate until the next step.

Liquid-liquid Extraction – Conduct in a darkened fume hood
1. Pipette into 1.5 mL microcentrifuge tube: 100 uL DI water and 100 uL dichloromethane
(DCM).
2. Pipette caged ATP reaction mixture into the centrifuge tube.
3. Close the tube and shake.
• Aqueous layer: base-caged ATP, translucent and clear
• Organic layer: nitrobenzylamine, orange
4. Centrifuge for 3-5 minutes. Extract aqueous layer.
5. Complete three rounds of L/L extraction, adding 50 uL DCM to the aqueous layer from
the previous extraction.
6. If the aqueous layer is still reddish in color, complete additional L/L extractions until the
aqueous layer is clear.

Column Chromatography Purification – Conduct in a darkened room
1. Add sodium bicarbonate to remove triethyl ammonium salt.
2. Rotovap to dryness (high vacuum 0.001 mm Hg). Resuspend in methanol.
3. Prepare a column with a slurry of silica gel and methanol. Pack a 10mL column so
that it is 75-80% silica gel.
4. Add sample and run two column volumes with methanol. Sodium bicarbonate will
stay at the top of the column, BC-ATP will stay on the column with methanol, and
NB-NH2 and other contaminants will elute with methanol.
5. Run column with diH2O to elute BC-ATP.
6. Collect diH2O fraction and protect from light.
7. Rotovap and resuspend to required concentration.
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APPENDIX B - LUCIFERASE PROTOCOL
ENLITEN® ATP Assay System (Promega) measured via Wallac 1420 Multilabel Counter
(PerkinElmer) in the LSU AgCenter Biotechnology Laboratory (ABL).
Preparation of assay
1. Reconstitute rLuciferase/Luciferin (rL/L) reagent according to the manufacturer’s
instructions.
2. Prepare rL/L buffer solution with dH2O:
a. 10mM Tris
b. 0.1mM EDTA
c. 25 mM MgCl2
d. Adjust to pH 7.5 with acetic acid.
3. Prepare 1:10 or 1:100 dilutions of rL/L reagent using the rL/L buffer solution as diluent.
4. Aliquot per usage requirements to minimize freeze-thaw cycles.
5. Use 96-well white opaque plate for assay.

Single Sample Luminescence
1. Set plate reader program to auto-inject 10 µL of luciferase assay solution into each well.
2. For ATP Standards (10-6, 10-7, 10-8 M ATP in purified water), place 5 µL of ATP
standard solutions in designated wells with 60 µL of ATP-free water each.
3. For caged and flashed samples, place 5 µL of sample in well with 60 µL of ATP-free
water.
4. Run Wallac protocol “Luminescence ATP (2)” in “by well” measurement mode

Co-Incubation Sample Luminescence
1. Set plate reader program to auto-inject 60 µL of luciferase assay solution into each well.
2. For ATP Standards (10-5, 10-6, 10-7 M ATP in purified water), place 7.5 µL of ATP
standard solutions in designated wells with 7.5 µL of ATP-free water each.
3. For caged and flashed co-incubations, place 7.5 µL of sample in well with 7.5 µL of
native ATP, 100 uM initial concentrations.
4. Run Wallac protocol “Luminescence ATP (2)” in “by well” measurement mode
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APPENDIX C - PLAN OF STUDY

Semester
Spring 2008
Spring 2008
Summer 2008
Summer 2008
Fall 2008
Spring 2009
Spring 2009
Summer 2009

Transfer Credit – Oklahoma State University
7000 Level
ETM 5111 - Introduction to Strategy, Technology, and Integration
IEM 5623 - Project Planning & Control Techniques
ETM 5251 - Problem Solving & Decision Making
ETM 5311 - Value Engineering
IEM 5503 - Finance and Advanced Capital Investment Analysis
ETM 5341 - Leadership Strategies
ETM 5351 - Planning Technical Projects
ETM 5381 - Design & Implementing Change in Technical Mgmt

Credits
1
3
1
1
3
1
1
1
12

LSU Credit
Semester
Fall 2007
Spring 2011
Spring 2011

4000 Level
IE 4520 - Supply Chain Logistics
Math 4999 - Independent Study
BE 4989 - Tissue Engineering

Credits
3
3
3
9

Semester
Spring 2011
Spring 2011
Summer 2011
Summer 2011

7000 Level
BE 7500 - Seminar
BE 8000 - Thesis
BE 7909 - Independent Study
BE 8000 - Thesis

Credits
1
3
3
3
10

Total Hours
4000 Level
7000 Level (includes 5000 level at OSU)

At least half of all hours must be at or above the 7000 Level
Must include one advanced math class
Must include BE 7500 Seminar
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31
9
22

APPENDIX D – LIST OF ABBREVIATIONS
ATP
DMNB
DMNB-NH2
DMNPE
DMSO
DNA
dsRNA
ESI-MS
HPLC
MALDI-MS
mG
miRNA
mRNA
MS
NA
NB
NB-NH2
NPE
nt
NTP
poly-A
PTGS
Rf
RISC
RLU
RNA
RNAi
rNTP
RP-HPLC
shRNA
siRNA
TEA
TEAA
TPE

adenosine 5’-triphosphate
4,5-dimethoxy-2-nitrobenzyl
4,5-dimethoxy-2-nitrobenzylamine
1-(4,5-dimethoxy-2-nitrophenyl)diazoethane
dimethyl sulfoxide
deoxyribonucleic acid
double-stranded RNA
electrospray ionization mass spectroscopy
high performance liquid chromatography
matrix-assisted laser desorption/ionization mass spectroscopy
5’ methylated guanosine triphosphate
microRNA
messenger RNA
mass spectroscopy
nucleic acid
2-nitrobenzyl
2-nitrobenzylamine
1-(2-nitrophenyl)ethyl
Nucleotide
Nucleoside triphosphate
poly-adenosine
post transcriptional gene silencing
resolution factor
RNA-induced silencing complex
Relative luminescence unit
ribonucleic acid
RNA interference
ribonucleotide tri-phosphate
Reverse phase high performance liquid chromatography
short hairpin RNA
small interfering RNA
triethylammonium
triethylammonium acetate
two-photon excitation
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